Impact of colorectal cancer screening on survival after metachronous metastasis

An increasing proportion of colorectal cancer (CRC) cases in Europe are detected by screening with faecal immunochemical testing (FIT). Previous studies showed that population screening with FIT leads to a decrease in CRC incidence and to detection at an earlier stage. However, approximately twenty percent of patients with CRC without metastases at initial diagnosis still develop metachronous metastases. We investigated the association between detection mode of the primary tumor and overall survival (OS) after metachronous metastasis in patients with CRC.

Source: European Journal of Cancer - November 12, 2023 Category: Cancer & Oncology Authors: Patricia A.H. Hamers, Geraldine R. Vink, Marloes A.G. Elferink, Leon M.G. Moons, Cornelis J.A. Punt, Anne M. May, Miriam Koopman Tags: Original Research Source Type: research